'Like iPhone 13 vs iPhone 12...Both Good, One Is Better' - Jefferies Weighs in on Omicron and New Covid Vaccine Boosters
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Moderna (MRNA) Announces UK Order for Additional 60M Vaccine Doses for 2022-2023
December 2, 2021 5:53 AM ESTModerna, Inc. (Nasdaq:... More
FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters
November 30, 2021 10:19 AM ESTAs we have with previous emerging COVID-19 variants, the U.S. Food and Drug Administration is actively working with our federal partners, international regulators and medical product companies to quickly address any potential impacts of the new omicron variant on the tools to fight the pandemic.
The agency is working as quickly as possible to evaluate the potential impact of this variant on the currently available diagnostics, therapeutics and vaccines. We are closely monitoring the situation and are committed to communicating with the public as we learn more.
Historically, the work to obtain the genetic information and... More
COVID-19 Omicron Variant: Analysts Discuss Which Biopharma Stock is Best Positioned
November 30, 2021 7:11 AM ESTAfter the WHO yesterday flagged the Omicron variant as concerning and high risk, markets have dipped this morning on fresh warning from Modernas CEO (NASDAQ: MRNA) about the effectiveness of existing vaccines.
"Omicron has an unprecedented number of spike mutations, some of which are concerning for their potential impact on the trajectory of the pandemic," the WHO said in its technical brief sent to nation members.
Oppenheimer analyst Hartaj Singh believes the new variant will add to uncertainty heading into the year-end. The analyst reminded investors that prior experience shows biotech... More
'This is Not Going To Be Good': Moderna CEO's Omicron Warning Sends Markets Tumbling
November 30, 2021 6:24 AM ESTEuropean and Asian shares trade in the red this morning after Modernas (NASDAQ: MRNA) CEO Stephane Bancel said he expects the companys vaccine to record lower protection against the COVID-19 Omicron variant than Delta.
"There is no world, I think, where (the effectiveness) is the same... More
